# OnCo record idea-bio2-mrd-coverage-with-evidence (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-bio2-mrd-coverage-with-evidence/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-bio2-mrd-coverage-with-evidence" ;
  schema:name "Pay for residual disease tests only inside a trial or registry"@en ;
  schema:description "Leftover-cancer blood tests are being sold faster than evidence that acting on them helps. Paying for them only when the result is recorded would generate the missing evidence."@en ;
  schema:url <https://onco.cc/ideas/idea-bio2-mrd-coverage-with-evidence/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2200075> ;
  onco:related <https://onco.cc/collections/seer/>, <https://onco.cc/collections/clinicaltrials-gov/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/> ;
  onco:terms <https://onco.cc/terms/real-world-evidence/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-dormancy-mrd/>, <https://onco.cc/bottlenecks/b-real-world-evidence/>, <https://onco.cc/bottlenecks/b-incentive-misalignment/> .